Medical Bulletin 21/May/2026 - Video

Here are the top medical news for today:

New Guidelines Recommend Earlier Cholesterol Treatment to Reduce Future Heart Disease Risk

A silent threat may begin building in the arteries decades before the first chest pain or stroke ever appears. Now, leading heart experts say doctors should stop waiting for warning signs and start treating high cholesterol earlier and more aggressively to prevent cardiovascular disease before it develops.

New recommendations from the American College of Cardiology and the American Heart Association encourage physicians to rethink how cholesterol is managed, especially in younger adults who may appear healthy but carry hidden cardiovascular risks.

Traditionally, doctors focused on whether someone was likely to suffer a heart attack or stroke within the next 10 years. But experts now argue that approach may miss younger adults who accumulate artery damage slowly over decades. Even moderately elevated cholesterol levels in early adulthood may raise long-term risk, particularly when combined with factors such as smoking, obesity, diabetes, poor sleep, or family history.

The updated guidance urges doctors to look beyond standard cholesterol tests. Newer tools, including lipoprotein(a), or Lp(a), testing and coronary artery calcium scans, can uncover hidden plaque buildup and inherited cardiovascular risk long before symptoms appear. Researchers say this broader assessment may help identify patients who could benefit from earlier lifestyle changes or cholesterol-lowering medications such as statins.

The recommendations also highlight challenges. Advanced cholesterol tests and newer medications may not always be affordable or widely available, raising concerns about widening health disparities. Experts say better insurance coverage, stronger collaboration between primary care doctors and specialists, and improved patient education will be essential for successful implementation.

Ultimately, researchers believe shifting from “treating disease” to “preventing disease” could save countless lives.

REFERENCE: Sterling, M. R., & Spatz, E. S. (2026). Putting the 2026 Dyslipidemia Guideline Into Action in Primary Care. JACC. DOI: 10.1016/j.jacc.2026.03.058. https://www.jacc.org/doi/10.1016/j.jacc.2026.03.058

New Study Reveals Water’s Unexpected Function in Brain Memory and Learning Processes

A microscopic gate inside the brain may hold the secret to how humans learn, remember, and even develop certain neurological disorders. Scientists have now captured the clearest view yet of how brain cells distinguish between two nearly identical minerals — calcium and magnesium — during the process that powers memory formation.

Researchers at Cold Spring Harbor Laboratory discovered how specialized brain receptors known as NMDARs selectively allow calcium to pass while blocking magnesium, a process essential for learning and memory.

At the center of the discovery is a tiny molecular structure called the “Asn cage,” which acts like a microscopic sieve inside the NMDAR channel. Both calcium and magnesium carry the same electrical charge and are chemically similar, making them difficult for the brain to distinguish. But the researchers found one critical difference: magnesium clings much more tightly to surrounding water molecules than does.

Using advanced single-particle cryo-electron microscopy, scientists recorded nearly 50,000 molecular “movies” to observe this process in unprecedented detail. The images revealed that magnesium, still wrapped in water molecules, becomes trapped outside the channel like debris caught in a strainer. Calcium, however, sheds its surrounding water more easily, allowing it to pass through the channel and activate crucial brain signaling pathways.

The discovery solves a scientific mystery that researchers have debated since the 1980s. Earlier theories suggested dehydration played a role in calcium transport, but technology at the time could not directly visualize the process. Advances in imaging and high-performance computing finally made it possible to observe the molecular interactions in real time.

Scientists say understanding exactly how these molecular gates function could eventually help researchers develop targeted treatments for neurological disorders linked to abnormal brain signaling.

REFERENCE: Steigerwald, R., et al. (2026). Molecular mechanism of calcium permeability and magnesium block in NMDA receptors. Nature Neuroscience. DOI: 10.1038/s41593-026-02283-3. https://www.nature.com/articles/s41593-026-02283-3

Scientists Identify Hidden Brain Nutrient Deficit Potentially Linked to Anxiety Disorders

Anxiety may leave a chemical fingerprint inside the brain — and scientists say one essential nutrient could be part of the story. New research from UC Davis Health has found that people with anxiety disorders consistently show lower levels of choline, a nutrient critical for memory, mood regulation, and nerve signaling.

The study, published in the journal Molecular Psychiatry, analyzed brain chemistry data from 25 earlier studies involving more than 700 participants. Researchers discovered that people diagnosed with anxiety disorders had roughly 8% lower levels of choline in key brain regions compared to individuals without anxiety.

The strongest difference appeared in the prefrontal cortex, an area involved in emotional regulation, decision-making, and stress control. Scientists say this is the first large meta-analysis to identify such a consistent chemical pattern across different anxiety disorders, including generalized anxiety disorder, panic disorder, social anxiety, and phobias.

Choline is an essential nutrient the body uses to build cell membranes and support brain communication. While the liver produces small amounts naturally, most choline must come from food sources such as eggs, fish, milk, chicken, soybeans, and beef.

Researchers believe chronic “fight-or-flight” activity may increase the brain’s demand for choline. Over time, the brain may struggle to maintain adequate levels, particularly in areas heavily involved in stress processing. Scientists also observed changes in another brain chemical called NAA, linked to neuron health, although the clearest finding remained reduced choline levels.

The study does not prove that low choline intake causes anxiety or that supplements can treat it. Researchers stress that more clinical trials are needed before recommending choline supplementation for anxiety disorders.

Scientists say the research opens a promising new direction for understanding anxiety biology and exploring whether diet could eventually support traditional mental health treatments alongside therapy and medication.

REFERENCE: Richard J. Maddock, Jason Smucny. Transdiagnostic reduction in cortical choline-containing compounds in anxiety disorders: a 1H-magnetic resonance spectroscopy meta-analysis. Molecular Psychiatry, 2025; 30 (12): 6020 DOI: 10.1038/s41380-025-03206-7